Mei Solutions

MEI Pharma’s $100 million investment in Litecoin has sparked a surge in the cryptocurrency’s value, positioning it as a top performer in the market and fueling optimism among investors and analysts.

MEI Pharma, a NASDAQ-listed pharmaceutical company, has made a $100 million investment in Litecoin, marking a pioneering move for a public company to integrate a cryptocurrency into its treasury strategy.

MEI Pharma has made a strategic $100 million investment in Litecoin, marking a significant move towards integrating cryptocurrency into corporate financial management and positioning the company as a pioneer in the field.